Skip to main content

Y-mAbs Therapeutics, Inc.

YMABDelisted Sep 16, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001722964

Y-mAbs Therapeutics, Inc. was delisted on Sep 16, 2025; its insiders filed their last Form 4 on Sep 19, 2025; 97 institutions reported holding it in 13F filings for Q2 2025, worth $125.9M in total; no superinvestor held it.

Members of Congress who traded YMAB

No member of Congress has reported a trade in Y-mAbs Therapeutics, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.